Salivary immunoglobulin A levels of persons who have stopped smoking

Objective. The aim of this study was to determine salivary immunoglobulin A levels in people who stopped smoking for at least 2 weeks. Salivary immunoglobulin A is a primary antibody at mucosal surfaces. Study Design. Salivary immunoglobulin A levels of each of 20 subjects were determined on 3 occas...

Full description

Saved in:
Bibliographic Details
Published in:Oral surgery, oral medicine, oral pathology, oral radiology and endodontics Vol. 87; no. 2; pp. 170 - 173
Main Authors: Griesel, A.G., Germishuys, P.J.
Format: Journal Article
Language:English
Published: St. Louis, MO Mosby, Inc 01-02-1999
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective. The aim of this study was to determine salivary immunoglobulin A levels in people who stopped smoking for at least 2 weeks. Salivary immunoglobulin A is a primary antibody at mucosal surfaces. Study Design. Salivary immunoglobulin A levels of each of 20 subjects were determined on 3 occasions: first, while the subject was still smoking; second, 7 days after cessation of smoking; third, on the 14th day after cessation. Two control groups (with 20 people in each group) were also used: the members of the first had never smoked, and the members of the second were current smokers. Results were analyzed through use of a repeated-measures analysis of variance and the t test. Results. Seven days after cessation of the smoking habit, a transient decrease in salivary immunoglobulin A levels was observed. However, within 14 days the levels returned to normal. Conclusions. Salivary immunoglobulin A levels transiently decrease in people who have stopped smoking for 7 days, but they recover to normal values within 2 weeks after cessation of the habit.(Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87:170-3)
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1079-2104
1528-395X
DOI:10.1016/S1079-2104(99)70268-4